• DOI:10.1136/gut.2010.222893
Corpus ID: 25614617

Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study

@article{Coelho2010PregnancyOI,
  title={Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study},
  author={J{\'e}ssica Coelho and Laurent Beaugerie and Jean Fr{\'e}d{\'e}ric Colombel and Xavier H{\'e}buterne and Eric Lerebours and Marc L{\'e}mann and Philippe Baumer and Jacques Cosnes and Arnaud Bourreille and Jean Pierre Gendre and Philippe Seksik and Antoine Blain and Etienne Henry Metman and Andr{\'e}e Nisard and Guillaume Cadiot and Michel Veyrac and Benoit Coffin and Xavier Dray and Fabrice Carrat and Philippe Marteau},
  journal={Gut},
  year={2010},
  volume={60},
  pages={198 - 203}
}

Jéssica Coelho, Laurent Beaugerie, +17 authors Philippe Marteau

Published 2010

Medicine

Gut

Background and aims Few studies have been conducted addressing the safety of thiopurine treatment in pregnant women with inflammatory bowel disease (IBD). The aim of this study was to evaluate the pregnancy outcome of women with IBD who have been exposed to thiopurines. Methods 215 pregnancies in 204 women were registered and documented in the CESAME cohort between May 2004 and October 2007. Physicians documented the following information from the women: last menstrual date, delivery term… CONTINUE READING

View on BMJ

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed